'Orion Nebula" and earlier "BK" - thanks so much for taking the time to clarify why "curing cancer" is not a realistic outcome for Kevetrin, even if it is successful beyond our wildest dreams. Way too much talk about curing what obviously is a host/multitude of disease states broadly classified as "cancer. Will select patients be cured of cancer, I believe so, how many and what type remains to be seen. By the way, most solid tumor cancers are not considered "cured" until a they are five years disease free after treatment, even then some relapse but the odds are in your favor at that milestone, thus it is used as a measurement milestone. So even now, if a patient in our Kevetrin trial had a complete response and had no observable disease, they are not "cured". We need to be mindful of how we use that term. Not trying to be a wet blanket, we just need to keep it real. That said, the progress we have made is fantastic. The fact that multiple patients with refractory disease have completed multiple courses is very noteworthy. The fact that we already know there is documented tumor reduction at what the experts believe is sub optimal doses is also fantastic. I just don't understand the folks who are upset with the progress here. This is not a get rich tomorrow stock, biotechs and PI/II or III trials always take longer than expected. The fact we will have multiple trials this year is great news. They would not be considering starting the other Kevetrin trials if the evidence of its utility was not there. Wish there was a post recommendation feature here. Orion, BK & Biohedge your posts are very worthy, as are many others here - not trying to leave others out. Good luck to all!
News 
Market Data 
Discover 
AI
